Celanese Corporation

Equities

CE

US1508701034

Specialty Chemicals

Market Closed - Nyse 21:00:02 12/09/2024 BST 5-day change 1st Jan Change
119.88 USD -0.51% Intraday chart for Celanese Corporation -1.28% -22.84%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Celanese Corporation Appoints Bruce Chinn to its Board of Directors, Effective September 15, 2024 CI
Celanese Shares Decline Following Piper Sandler Downgrade MT
Piper Sandler Downgrades Celanese to Neutral From Overweight, Adjusts Price Target to $150 From $180 MT
Nanoform Finland, Celanese Extend Partnership to Cover Biologics Drug Delivery MT
Nanoform and Celanese Expand Collaboration into Long-Acting Biologics Delivery Through Small Implants CI
Deutsche Bank Adjusts Price Target on Celanese to $135 From $160, Maintains Hold Rating MT
Deutsche Bank Adjusts Celanese's PT to $135 From $160, Maintains Hold Rating MT
Analyst recommendations: Biogen, Cloudflare, Doordash, Moderna, Diageo... Our Logo
Celanese lifts force majeure condition for some products sold in western hemisphere RE
Celanese Corporation Lifts Force Majeure on Western Hemisphere Acetic Acid and VAM CI
RBC Cuts Price Target on Celanese to $167 From $168 MT
BMO Capital Adjusts Price Target on Celanese to $138 From $142 MT
Jefferies & Co Adjusts Celanese Price Target to $140 From $155 MT
Citigroup Adjusts Price Target on Celanese to $140 From $148, Maintains Neutral Rating MT
Barclays Adjusts Price Target on Celanese to $151 From $170, Equalweight Rating Maintained MT
From Boom to Doom Our Logo
Vertical Research Adjusts Price Target on Celanese to $144 From $157 MT
Baird Adjusts Price Target on Celanese to $150 From $180, Maintains Outperform Rating MT
KeyBanc Adjusts Price Target on Celanese to $178 From $180, Maintains Overweight Rating MT
Wells Fargo Adjusts Price Target on Celanese to $165 From $180, Maintains Overweight Rating MT
Analyst recommendations: Albemarle, Dexcom, Intel, Kellanova, Lloyds... Our Logo
JPMorgan Upgrades Celanese to Neutral From Underweight, Adjusts Price Target to $130 From $156 MT
Tranche Update on Celanese Corporation (NYSE:CE)'s Equity Buyback Plan announced on April 18, 2019. CI
Tranche Update on Celanese Corporation (NYSE:CE)'s Equity Buyback Plan announced on July 14, 2021. CI
UBS Adjusts Celanese Price Target to $177 From $184, Maintains Buy Rating MT
Chart Celanese Corporation
More charts
Logo Celanese Corporation
Celanese Corporation specializes in the manufacture and marketing of chemicals and specialty materials. The products are intended for the production of automotive components, beverages and food products, cigarette filters, paints and coatings, packaging, textiles, etc. Net sales by category of products break down as follows: - acetyl products (55.7%); - high performance engineering polymers (44.3%). Net sales are distributed geographically as follows: the United States (25.8%), Germany (22.6%), China (17.8%), Singapore (10.5%), Belgium (4.6%), Mexico (3.3%), Japan (2.9%), Switzerland (2%), India (1.4%), South Korea (1.4%), Brazil (1.3%), Canada (1.3%), France ( 0.8%), the United Kingdom (0.8%), Italy (0.7%), Spain (0.5%), and other (2.3%).
Employees
12,410
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
119.88USD
Average target price
149.90USD
Spread / Average Target
+25.04%
Consensus
  1. Stock Market
  2. Equities
  3. CE Stock
  4. News Celanese Corporation
  5. Barclays Adjusts Price Target on Celanese to $151 From $170, Equalweight Rating Maintained
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW